Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway

Fig. 7

Rapamycin attenuated the oncogenic effects of HKDC1 in LUAD cells. a Rapamycin attenuated the proliferative ability of HKDC1 in LUAD cells. b, c Rapamycin attenuated the migratory and invasive ability of HKDC1 in LUAD cells (scale bar, 100 μm). d Rapamycin attenuated the glycolytic effect of HKDC1 in LUAD cells. e Rapamycin attenuated the EMT effect of HKDC1 in LUAD cells. Data were expressed as the mean ± standard deviation (mean ± SD) *p < 0.05, **p < 0.01

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us